DNA Chip Research

DNA Chip Research Inc. is a Japanese biotechnology company focused on genomic analysis and the development of clinical diagnostic tools. Established in 1999 as a venture from the Tokyo Institute of Technology, the company leverages DNA microarray and next-generation sequencing (NGS) technologies to provide services for gene expression profiling and mutation analysis. Their primary clinical offering is the Lung Cancer Compact Panel, a diagnostic system that detects multiple gene alterations to guide personalized treatment for lung cancer patients. Additionally, the company provides contract research services for pharmaceutical companies and academic institutions, as well as non-invasive prenatal testing (NIPT). The company is publicly traded on the Tokyo Stock Exchange and continues to expand its portfolio in liquid biopsy and personalized medicine.